Eric Warren
Chief Commercial Officer · 2 filings · Latest: Jul 21, 2026
Mineralys Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
MLYS | Eric Warren | Chief Commercial Officer | Jul 21, 2026 | Sale | $26.87 | 7,438 | $199.9K | 38,400 | |
MLYS | Eric Warren | Chief Commercial Officer | Jul 21, 2026 | Option Exercise | $13.24 | 7,438 | $98.5K | 45,838 | |
MLYS | Warren Eric | — | Jul 21, 2026 | Proposed Sale | $26.87 | 7,438 | $199.9K | — | |
MLYS | Eric Warren | Chief Commercial Officer | Jun 26, 2026 | Sale | $25.90 | 104,124 | $2.7M | 38,400 | |
MLYS | Eric Warren | Chief Commercial Officer | Jun 26, 2026 | Option Exercise | $13.24 | 104,124 | $1.4M | 142,524 | |
MLYS | Warren Eric | — | Jun 26, 2026 | Proposed Sale | $25.90 | 104,124 | $2.7M | — | |
ESPR | Warren Eric | — | Apr 17, 2025 | Proposed Sale | $0.9775 | 108 | $106 | — | |
ESPR | Warren Eric | — | Mar 18, 2025 | Proposed Sale | $1.49 | 2,433 | $3.6K | — | |
ESPR | Warren Eric | — | Feb 19, 2025 | Proposed Sale | $1.87 | 239 | $446 | — | |
ESPR | Warren Eric | — | Jan 17, 2025 | Proposed Sale | $2.26 | 123 | $278 | — | |
ESPR | Warren Eric | — | Dec 17, 2024 | Proposed Sale | $2.43 | 2,234 | $5.4K | — | |
ESPR | Warren Eric | — | Nov 19, 2024 | Proposed Sale | $2.17 | 197 | $427 | — | |
ESPR | Warren Eric | — | Oct 17, 2024 | Proposed Sale | $2.12 | 107 | $227 | — | |
ESPR | Warren Eric | — | Sep 17, 2024 | Proposed Sale | $1.78 | 2,608 | $4.7K | — |